Wednesday, February 10, 2010, 7:13am EST - Canadian Markets open in 2 hours and 17 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Anika Therapeutics Inc. (ANIK)

 On Feb 9: 6.49 USD   0.00 (0.00%)  
MORE ON ANIK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Anika Therapeutics Inc. (NasdaqNM:ANIK) Delayed quote dataEdit
Last Trade: 6.49 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 6.49
Open: N/A
Bid: 6.07 x 200
Ask: 7.75 x 2000
1y Target Est: 18.00
Day's Range: N/A - N/A
52wk Range: 3.00 - 9.25
Volume: 0
Avg Vol (3m): 47,093.7
Market Cap: 74.23M
P/E (ttm): 18.28
EPS (ttm): 0.36
Div & Yield: N/A (N/A%)
Anika Therapeutics Inc. (ANIK)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ANIK to Portfolio   Download Data

HEADLINES
• Anika Therapeutics to Discuss Acquisition of Fidia Advanced Biopolymers During Special Conference Call Today
Business Wire (Mon, Jan 4)
• Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Business Wire (Thu, Dec 31)
• Anika gets European approval on wrinkle product
AP (Thu, Nov 19)
• Anika Therapeutics Receives European CE Mark Approval for ELEVESS Light
Business Wire (Thu, Nov 19)
• ANIKA THERAPEUTICS INC Financials
EDGAR Online Financials (Sat, Nov 7)
• ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 3)
• Anika Therapeutics Earnings Call scheduled for 9:00 am ET today
CCBN (Wed, Oct 28)
• ANIKA THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex
EDGAR Online (Tue, Oct 27)
• ANIKA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Sep 14)
• ANIKA THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Aug 5)
More Headlines for ANIK...
ANALYST
EPS Est (next year) (Dec-09) : N/A
EPS Est (in 2 years) (Dec-10) : N/A
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices